News
On May 22, an FDA advisory committee unanimously recommended COVID-19 vaccine manufacturers target the JN.1 variant in their formulations. The Vaccines and Related Biological Products Advisory ...
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
18h
MedPage Today on MSNFDA Panel Recommends Monovalent COVID Vaccine for Next SeasonAn FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...
2h
AllAfrica on MSN12 African Countries Commit to Strengthen Cross-Border Collaboration for Improved Mpox and Health Emergency Response [press release]Twelve African countries have joined hands to facilitate stronger cross-border collaboration to respond, prevent and control disease outbreaks. The continent has recorded over 16,398 confirmed mpox ...
NPR interviews Maria Van Kherkove, the infectious disease epidemiologist who is a leader in the World Health Organization.
In a powerful demonstration of country-driven leadership and cross-border solidarity, Ministry of Health representatives from various African ...
The highly anticipated White House report on childhood diseases, titled "Make Our Children Healthy Again: Assessment," was ...
South Africa has approved the first mpox diagnostic test, bolstering efforts to improve testing access across the globe.
The Food and Drug Administration (FDA) vaccine advisory group today recommended sticking with a monovalent JN.1 lineage ...
SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results